Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)

Y. H. Ling; T. Li; Zi Qiang Yuan; Missak Haigentz; T. K. Weber; R. Perez-Soler

doi:10.1124/mol.115.08er15a

Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27^KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G₁/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)

Y. H. Ling, T. Li, Zi Qiang Yuan, Missak Haigentz, T. K. Weber, R. Perez-Soler

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	390
Number of pages	1
Journal	Molecular Pharmacology
Volume	88
Issue number	2
DOIs	https://doi.org/10.1124/mol.115.08er15a
State	Published - Aug 1 2015
Externally published	Yes

ASJC Scopus subject areas

Molecular Medicine
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1124/mol.115.08er15a

Cite this

Ling, Y. H., Li, T., Yuan, Z. Q., Haigentz, M., Weber, T. K., & Perez-Soler, R. (2015). Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27^KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G₁/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827). Molecular Pharmacology, 88(2), 390. https://doi.org/10.1124/mol.115.08er15a

Erratum : Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27^KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G₁/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827). / Ling, Y. H.; Li, T.; Yuan, Zi Qiang et al.

In: Molecular Pharmacology, Vol. 88, No. 2, 01.08.2015, p. 390.

Research output: Contribution to journal › Comment/debate › peer-review

Ling, YH, Li, T, Yuan, ZQ, Haigentz, M, Weber, TK & Perez-Soler, R 2015, 'Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27^KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G₁/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)', Molecular Pharmacology, vol. 88, no. 2, pp. 390. https://doi.org/10.1124/mol.115.08er15a

Ling YH, Li T, Yuan ZQ, Haigentz M, Weber TK, Perez-Soler R. Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27^KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G₁/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827). Molecular Pharmacology. 2015 Aug 1;88(2):390. doi: 10.1124/mol.115.08er15a

Ling, Y. H. ; Li, T. ; Yuan, Zi Qiang et al. / Erratum : Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27^KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G₁/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827). In: Molecular Pharmacology. 2015 ; Vol. 88, No. 2. pp. 390.

@article{cdd32521a82d4960bc33a9dc45f2c20a,

title = "Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)",

author = "Ling, {Y. H.} and T. Li and Yuan, {Zi Qiang} and Missak Haigentz and Weber, {T. K.} and R. Perez-Soler",

year = "2015",

month = aug,

day = "1",

doi = "10.1124/mol.115.08er15a",

language = "English (US)",

volume = "88",

pages = "390",

journal = "Molecular Pharmacology",

issn = "0026-895X",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

number = "2",

}

TY - JOUR

T1 - Erratum

T2 - Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)

AU - Ling, Y. H.

AU - Li, T.

AU - Yuan, Zi Qiang

AU - Haigentz, Missak

AU - Weber, T. K.

AU - Perez-Soler, R.

PY - 2015/8/1

Y1 - 2015/8/1

UR - http://www.scopus.com/inward/record.url?scp=84939785782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939785782&partnerID=8YFLogxK

U2 - 10.1124/mol.115.08er15a

DO - 10.1124/mol.115.08er15a

M3 - Comment/debate

C2 - 26130289

AN - SCOPUS:84939785782

SN - 0026-895X

VL - 88

SP - 390

JO - Molecular Pharmacology

JF - Molecular Pharmacology

IS - 2

ER -

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this